MT-2 and GHK-Cu peptide stacks: separating gym hype from evidence

What did @stanmilsom1 actually say?

Stan's pitch is simple: stack melanotan II (MT2) with GHK-Cu, get a tan, improve your skin quality, and "constantly glow and look good." He presents both peptides as cosmetic staples, not medical treatments. He credits MT2 with increasing "natural melanin" and GHK-Cu with improving "skin quality" and making you "better looking." No dosing, no mechanism beyond that, no caveats. It's a 30-second aesthetic endorsement with a flex.

The framing is worth noting: he calls this his personal "stack," positions the combo as synergistic, and uses his own appearance as evidence. That's anecdote dressed up as testimony, which is fine for a TikTok but worth unpacking before anyone runs to their peptide supplier.

Does the science back this up?

Partly, but the picture is messier than Stan makes it sound. MT2 does stimulate melanogenesis, and GHK-Cu does have credible data on skin remodeling. The problem is the gap between what studies show in controlled settings and what a nasal spray does in a healthy person chasing aesthetics.

MT2 (melanotan II) is a synthetic analog of alpha-melanocyte-stimulating hormone. It binds melanocortin receptors and does increase eumelanin production, producing a tan. That mechanism is real. Dorr et al. (1996, Journal of Investigative Dermatology) confirmed tanning effects in a small clinical trial. But MT2 also hits MC3R and MC4R receptors, which is why its side effect profile includes nausea, facial flushing, spontaneous erections, and appetite suppression. It is not a clean cosmetic compound.

GHK-Cu (copper peptide GHK-Cu) has a more legitimate skin science base. Pickart and Margolina (2018, Cosmetics) reviewed decades of data showing GHK-Cu upregulates collagen synthesis, activates antioxidant pathways, and improves skin density in aging models. Wound healing studies are the strongest evidence base here. Cosmetic efficacy in healthy young skin is far less established.

What did they get wrong (or right)?

He got the basic mechanism of MT2 right. It does increase melanin. That part is not controversial. Calling it "natural melanin" is a stretch, though, because the process is pharmacologically driven, not sun-induced. The skin may look tanned, but the pathway is receptor activation from an exogenous peptide, not UV exposure triggering normal melanocyte response. That distinction matters for anyone with a history of atypical moles or melanoma risk.

On GHK-Cu, the "improve skin quality" claim is the most defensible thing he said. There is actual peer-reviewed support for skin remodeling effects. What he skipped is that most of that data comes from topical application or in vitro work. Systemic use via nasal spray for cosmetic skin improvement is not well-studied in humans.

The "synergy" framing is unsubstantiated. No published research examines MT2 plus GHK-Cu as a combined protocol. He is extrapolating from two separate mechanisms and calling the result a stack. That is not science. It is gym-culture logic.

What should you actually know?

MT2 is not approved by the FDA, EMA, or TGA for any indication. It is sold as a research chemical. Its off-label nasal spray use is entirely outside any regulated clinical framework. The tanning effect is real, but so are the risks: studies have flagged concerns about MT2 accelerating growth of pre-existing melanocytic lesions (Yuen et al., 2010, Journal of the American Academy of Dermatology). Using a melanocortin agonist without dermatological screening is not a casual cosmetic move.

GHK-Cu has a cleaner safety profile in topical form. Systemic delivery changes the equation. The nasal route bypasses first-pass metabolism and delivers peptide systemically, which is a different exposure profile than a face cream. That is not automatically dangerous, but it is under-studied for cosmetic endpoints.

Anyone considering either compound should know: these are not supplements. They are bioactive peptides with receptor-level activity. Stacking them based on a TikTok is not the same as a medically supervised protocol. If you are using a regulated telehealth platform, this is exactly the kind of decision that warrants a clinician conversation, not just a creator's before-and-after glow.